CFD'er er komplekse instrumenter, og der er stor risiko for at miste penge hurtigt på grund af gearing. 84% af individuelle investorer taber penge, når de handler CFD'er med denne udbyder. Du bør overveje, om du forstår, hvordan CFD'er virker, og om du har råd til at løbe en høj risiko for at miste dine penge.
Capital Com Australia Pty Ltd Reguleret af ASIC Capital Com UK Limited Reguleret af Financial Conduct Authority (FCA) Capital Com SV Investments Limited Reguleret af CYSEC Сlosed Joint Stock Company «FinTech Solutions» Reguleret af NBRB Smart Forex Broker LLC Capital Com Stock and CFD Investing Ltd Reguleret af FSA Capital Com Online Investments Ltd Reguleret af SCB Our Global Offices

Scan to Download iOS&Android APP

English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文
Du kan også kontakte os: ring +44 2030978888 support@capital.com

Handel BioCryst - BCRX CFD

8.49
0.47%
0.07
Lav: 8.43
Høj: 8.56
Market Trading Hours* (UTC) Open now
Closes on Tuesday at 20:00

Mon - Fri: 13:30 - 20:00

  • Opsummering
  • Historisk Data
  • Begivenheder
  • Resultatopgørelse
  • Saldo
  • Cash flow
  • Ejerskab
Handelsbetingelser
Spænd 0.07
Long position, gebyr natten over

Long position overnight fee

Margin. Your investment $1,000.00
Gebyr for natten over -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
Gå til platform
-0.024068%
Short position, gebyr natten over

Short position overnight fee

Margin. Your investment $1,000.00
Gebyr for natten over 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
Gå til platform
0.001846%
Gebyr natten over, tid 21:00 (UTC)
Min. handlet mængde 1
Valuta USD
Margen 20%
Aktiebørs United States of America
Kommission på handel 0%

*Information provided by Capital.com

Nøglestatistikker
Tidligere luk* 8.44
Åben* 8.48
1-Års Ændring* -46.73%
Dagens Spænd* 8.43 - 8.56
52-Ugers Spænd 7.61-18.00
Gennemsnitlig Volumen (10 dage) 2.84M
Gennemsnitlig Volumen (3 måneder) 61.63M
Market Cap 1.60B
P/E-forhold -100.00K
Udestående aktier 188.45M
Omsætning 270.83M
EPS -1.33
Dividend (Udbytte %) N/A
Beta 2.03
Næste indtjeningsopgørelse May 3, 2023

Al data kommer fra Refinitiv, med undtagelse af data markeret med en asterisk, som er *data fra Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Luk Change Change (%) Åben High Low
Mar 27, 2023 8.44 -0.03 -0.35% 8.47 8.53 8.34
Mar 24, 2023 8.48 0.36 4.43% 8.12 8.53 8.07
Mar 23, 2023 8.09 0.15 1.89% 7.94 8.28 7.91
Mar 22, 2023 7.90 -0.15 -1.86% 8.05 8.20 7.89
Mar 21, 2023 8.13 0.14 1.75% 7.99 8.20 7.91
Mar 20, 2023 7.97 -0.10 -1.24% 8.07 8.10 7.91
Mar 17, 2023 8.05 0.01 0.12% 8.04 8.15 7.97
Mar 16, 2023 8.14 -0.07 -0.85% 8.21 8.40 8.13
Mar 15, 2023 8.34 0.21 2.58% 8.13 8.57 8.12
Mar 14, 2023 8.29 -0.14 -1.66% 8.43 8.57 8.22
Mar 13, 2023 8.29 0.11 1.34% 8.18 8.51 8.15
Mar 10, 2023 8.26 0.11 1.35% 8.15 8.27 7.79
Mar 9, 2023 8.17 -0.32 -3.77% 8.49 8.60 8.06
Mar 8, 2023 8.52 -0.08 -0.93% 8.60 8.65 8.36
Mar 7, 2023 8.63 -0.19 -2.15% 8.82 8.87 8.62
Mar 6, 2023 8.81 0.07 0.80% 8.74 8.81 8.64
Mar 3, 2023 8.75 -0.13 -1.46% 8.88 8.91 8.71
Mar 2, 2023 8.81 0.15 1.73% 8.66 8.87 8.59
Mar 1, 2023 8.79 -0.04 -0.45% 8.83 8.90 8.60
Feb 28, 2023 8.81 -0.17 -1.89% 8.98 9.10 8.74

BioCryst Events

Tid (UTC) (UTC) Land Begivenhed
No events scheduled
Se alle begivenheder
  • Årlig
  • Pr kvartal
2022 2021 2020 2019 2018
Total omsætning 270.827 157.17 17.812 48.835 20.653
Omsætning 270.827 157.17 17.812 48.835 20.653
Kost af omsætning, Total 6.594 7.264 1.676 4.101 0.471
Bruttofortjeneste 264.233 149.906 16.136 44.734 20.182
Totale Driftsudgifter 419.262 279.052 194.58 148.29 114.873
Salgs/Generelle/Admin. Udgifter, Total 159.371 118.818 67.929 37.121 13.614
Forskning & Udvikling 253.297 208.808 122.964 107.068 84.888
Driftsindtægter -148.435 -121.882 -176.768 -99.455 -94.22
Renteindkomst (Udgift), Netto Ikke-Drift -95.948 -59.927 -6.046 -9.442 -7.032
Netto Indkomst Før Skat -244.383 -181.809 -182.814 -108.897 -101.252
Netto Indkomst Efter Skat -247.116 -184.062 -182.814 -108.897 -101.252
Netto Indkomst Før Ekstra Ting -247.116 -184.062 -182.814 -108.897 -101.252
Netto Indkomst -247.116 -184.062 -182.814 -108.897 -101.252
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting -247.116 -184.062 -182.814 -108.897 -101.252
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting -247.116 -184.062 -182.814 -108.897 -101.252
Fortyndet Netto Indkomst -247.116 -184.062 -182.814 -108.897 -101.252
Fortyndet Vægtet Gennemsnit Aktier 185.908 179.117 167.267 115.6 103.185
Fortyndet EPS Uden Ekstraordinære Ting -1.32924 -1.02761 -1.09295 -0.94202 -0.98127
Dividends per Share - Common Stock Primary Issue
Fortyndet Normaliseret EPS -1.32924 -1.23024 -1.08092 -0.94202 -0.82717
Totale Ekstraordinære Ting
Usædvanlig Udgift (Indkomst) 0 -55.838 2.011 15.9
Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021
Total omsætning 79.545 75.827 65.532 49.923 47.158
Omsætning 79.545 75.827 65.532 49.923 47.158
Kost af omsætning, Total 2.496 3.613 0.247 0.238 0.419
Bruttofortjeneste 77.049 72.214 65.285 49.685 46.739
Totale Driftsudgifter 125.856 93.272 100.254 99.88 43.497
Salgs/Generelle/Admin. Udgifter, Total 50.153 36.919 38.017 34.282 35.387
Forskning & Udvikling 73.207 52.74 61.99 65.36 63.529
Driftsindtægter -46.311 -17.445 -34.722 -49.957 3.661
Renteindkomst (Udgift), Netto Ikke-Drift -25.154 -23.553 -23.281 -23.96 -19.187
Netto Indkomst Før Skat -71.465 -40.998 -58.003 -73.917 -15.526
Netto Indkomst Efter Skat -71.541 -42.52 -58.859 -74.196 -17.779
Netto Indkomst Før Ekstra Ting -71.541 -42.52 -58.859 -74.196 -17.779
Netto Indkomst -71.541 -42.52 -58.859 -74.196 -17.779
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting -71.541 -42.52 -58.859 -74.196 -17.779
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting -71.541 -42.52 -58.859 -74.196 -17.779
Fortyndet Netto Indkomst -71.541 -42.52 -58.859 -74.196 -17.779
Fortyndet Vægtet Gennemsnit Aktier 186.934 186.18 185.605 184.898 181.871
Fortyndet EPS Uden Ekstraordinære Ting -0.38271 -0.22838 -0.31712 -0.40128 -0.09776
Dividends per Share - Common Stock Primary Issue 0 0 0
Fortyndet Normaliseret EPS -0.38271 -0.22838 -0.31712 -0.40128 -0.29732
Usædvanlig Udgift (Indkomst) 0 -55.838
  • Årlig
  • Pr kvartal
2021 2020 2019 2018 2017
Totale Nuværende Aktiver 566.136 323.8 164.345 114.352 125.391
Likvider og Kortsigtede Investeringer 507.601 300.366 136.226 104.467 114.397
Likvider & Lignende 504.389 272.127 114.172 26.731 50.282
Kortsigtede Investeringer 3.212 28.239 22.054 77.736 64.115
Totale Tilgodehavender, Netto 29.413 8.646 22.146 4.293 6.117
Accounts Receivable - Trade, Net 29.413 8.646 22.146 4.293 6.117
Total Inventory 15.791 7.039 0 1.649
Prepaid Expenses 9.986 5.528 4.422 2.39 1.381
Other Current Assets, Total 3.345 2.221 1.551 1.553 3.496
Total Assets 588.151 334.715 175.282 146.841 178.259
Property/Plant/Equipment, Total - Net 15.186 10.915 10.937 9.135 9.546
Property/Plant/Equipment, Total - Gross 25.925 20.892 18.911 15.23 14.873
Accumulated Depreciation, Total -10.739 -9.977 -7.974 -6.095 -5.327
Long Term Investments 6.829 0 22.376 41.295
Other Long Term Assets, Total 0.978 2.027
Total Current Liabilities 103.718 105.654 92.335 69.477 74.836
Accounts Payable 27.808 18.713 13.988 7.769 6.337
Accrued Expenses 74.489 56.791 37.646 27.739 24.794
Notes Payable/Short Term Debt 0 30 29.561 29.121 28.682
Other Current Liabilities, Total 1.421 0.15 2.12 0.221 8.484
Total Liabilities 695.137 353.977 137.03 97.606 94.492
Total Long Term Debt 585.457 244.452 41.289 28.075 19.501
Long Term Debt 585.457 244.452 41.289 25.372 16.75
Capital Lease Obligations 2.703 2.751
Other Liabilities, Total 5.962 3.871 3.406 0.054 0.155
Total Equity -106.986 -19.262 38.252 49.235 83.767
Preferred Stock - Non Redeemable, Net 0 0 0 0
Common Stock 1.843 1.769 1.541 1.101 0.984
Additional Paid-In Capital 1098.5 1002.41 877.3 780.4 714.869
Retained Earnings (Accumulated Deficit) -1207.5 -1023.44 -840.628 -731.969 -631.843
Other Equity, Total 0.177 0.003 0.039 -0.297 -0.243
Total Liabilities & Shareholders’ Equity 588.151 334.715 175.282 146.841 178.259
Total Common Shares Outstanding 184.35 176.883 154.082 110.063 98.411
Current Port. of LT Debt/Capital Leases 0 9.02 4.627 6.539
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Totale Nuværende Aktiver 511.714 566.136 252.743 265.802 273.771
Likvider og Kortsigtede Investeringer 443.468 507.601 199.597 218.428 240.356
Likvider & Lignende 395.504 504.389 199.597 210.314 226.902
Kortsigtede Investeringer 47.964 3.212 0 8.114 13.454
Totale Tilgodehavender, Netto 36.415 29.413 26.212 27.62 18.386
Accounts Receivable - Trade, Net 36.415 29.413 26.212 27.62 18.386
Total Inventory 16.144 15.791 13.663 9.846 5.113
Prepaid Expenses 12.333 9.986 8.975 5.56 5.908
Other Current Assets, Total 3.354 3.345 4.296 4.348 4.008
Total Assets 527.72 588.151 265.763 277.284 284.431
Property/Plant/Equipment, Total - Net 16.006 15.186 13.02 11.482 10.66
Property/Plant/Equipment, Total - Gross 9.098 7.519 5.924 6.565
Accumulated Depreciation, Total -3.019 -2.626 -2.328 -2.111 -2.94
Total Current Liabilities 81.017 103.718 133.608 115.601 101.201
Accounts Payable 13.881 27.808 19.693 10.087 13.529
Accrued Expenses 65.665 74.489 83.313 74.963 57.267
Notes Payable/Short Term Debt 0 0 30 30 30
Other Current Liabilities, Total 1.471 1.421 0.602 0.551 0.405
Total Liabilities 691.935 695.137 412.807 383.359 359.419
Total Long Term Debt 604.461 585.457 274.164 263.658 254.335
Long Term Debt 604.461 585.457 274.164 263.658 254.335
Other Liabilities, Total 6.457 5.962 5.035 4.1 3.883
Total Equity -164.215 -106.986 -147.044 -106.075 -74.988
Preferred Stock - Non Redeemable, Net 0 0 0 0 0
Common Stock 1.856 1.843 1.798 1.787 1.777
Additional Paid-In Capital 1115.44 1098.5 1040.77 1022.97 1010.78
Retained Earnings (Accumulated Deficit) -1281.7 -1207.5 -1189.72 -1130.92 -1087.73
Other Equity, Total 0.186 0.177 0.114 0.087 0.182
Total Liabilities & Shareholders’ Equity 527.72 588.151 265.763 277.284 284.431
Total Common Shares Outstanding 185.572 184.35 179.791 178.725 177.67
Long Term Investments 0 6.829
  • Årlig
  • Pr kvartal
2021 2020 2019 2018 2017
Netto indkomst/Startlinje -184.062 -182.814 -108.897 -101.252 -65.782
Likvider Fra Driftsaktiviteter -142.157 -135.108 -89.584 -92.565 -41.143
Likvider Fra Driftsaktiviteter 0.777 0.748 0.724 0.77 0.704
Ikke-Likvide Ting 33.004 20.083 19.461 11.447 14.608
Ændringer i Driftskapital 8.124 26.875 -0.872 -3.53 9.327
Likvider fra Investeringsaktiviteter 15.804 -6.856 77.934 4.768 -64.642
Kapitaludgifter -2.385 -0.514 -0.343 -0.366 -0.328
Andre Investerings-Cash-Flow-Ting, Total 18.189 -6.342 78.277 5.134 -64.314
Likvider fra Financieringsaktiviteter 359.668 300.589 99.098 62.504 135.703
Udstedelse (Pensionering) af Aktier, Netto 65.794 110.542 79.621 56.252 135.581
Udstedelse (Pensionering) af Gæld, Netto 293.874 190.047 19.477 6.252 0.122
Netto Ændring i Likviditet 233.386 158.625 87.448 -25.293 29.918
Udenlandsk Børs Effekter 0.071
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line -74.196 -184.062 -166.283 -107.482 -64.284
Cash From Operating Activities -77.8 -142.157 -109.698 -86.422 -61.011
Cash From Operating Activities 0.317 0.777 0.606 0.377 0.178
Non-Cash Items 28.634 33.004 62.615 35.809 16.52
Changes in Working Capital -32.555 8.124 -6.636 -15.126 -13.425
Cash From Investing Activities -38.472 15.804 26.924 19.177 14.673
Capital Expenditures -0.406 -2.385 -1.277 -0.912 -0.099
Other Investing Cash Flow Items, Total -38.066 18.189 28.201 20.089 14.772
Cash From Financing Activities 7.356 359.668 12.25 7.474 2.9
Issuance (Retirement) of Stock, Net 7.356 65.794 12.25 7.474 2.9
Net Change in Cash -108.876 233.386 -70.455 -59.686 -43.438
Foreign Exchange Effects 0.04 0.071 0.069 0.085
Issuance (Retirement) of Debt, Net 293.874 0
Investornavn Investortype Procent udestående Aktiebeholdning Aktieændring Beholdningsdato IOmsætningsscore
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 7.5177 14167131 359744 2022-12-31 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 6.9264 13052882 1132849 2022-12-31 LOW
Baker Bros. Advisors LP Hedge Fund 6.7449 12710818 0 2022-12-31 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 5.9044 11126861 1722614 2022-12-31 LOW
Avoro Capital Advisors LLC Investment Advisor/Hedge Fund 4.8023 9050000 0 2022-12-31 LOW
Fidelity Management & Research Company LLC Investment Advisor 3.1084 5857788 1330751 2022-12-31 LOW
Pictet Asset Management Ltd. Investment Advisor/Hedge Fund 2.8046 5285348 471576 2022-12-31 LOW
Fisher Investments Investment Advisor/Hedge Fund 2.3513 4431114 -732731 2022-12-31 LOW
RP Management, LLC Private Equity 2.0409 3846154 0 2022-12-31 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.8395 3466550 100706 2022-12-31 LOW
Artisan Partners Limited Partnership Investment Advisor 1.5274 2878427 228811 2022-12-31 LOW
BNP Paribas Asset Management USA, Inc. Investment Advisor 1.4181 2672382 562718 2022-12-31 LOW
Assenagon Asset Management S.A. Investment Advisor 1.3746 2590392 -25765 2022-12-31 HIGH
Fairmount Funds Management LLC Hedge Fund 1.3495 2543107 0 2022-12-31 HIGH
Victory Capital Management Inc. Investment Advisor/Hedge Fund 1.3444 2533584 -986647 2022-12-31 LOW
Two Sigma Investments, LP Hedge Fund 1.3185 2484819 -562152 2022-12-31 HIGH
PFM Health Sciences, LP Hedge Fund 1.1475 2162411 0 2022-12-31 MED
Woodline Partners LP Hedge Fund 1.0989 2070983 2070983 2022-12-31 HIGH
Janus Henderson Investors Investment Advisor/Hedge Fund 1.0878 2050026 2014048 2022-12-31 LOW
Point72 Asset Management, L.P. Hedge Fund 1.0552 1988627 1988627 2022-12-31 HIGH

Hvorfor vælge Capital.com? Vores tal taler for sig selv.

Capital.com Group

500K+

Handlende

92K+

Månedlkige, aktive klienter

$53M+

Månedlig investeringsvolumen

$30M+

Hævet hver måned

Handelslommeregner

Udregn dit hypotetiske P&L hvis du havde åbnet en CFD-handel på en given dato (vælg en dato) og lukket den på en anden dato (vælg en dato).

Handelskurtage
0
  • 1:1
Gearing
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investering
Handelsstørrelse (Gearing x Investering):
Åben

Luk

Short Long
Tidligere resultater er ikke en pålidelig indikator for fremtidige resultater
Fortjeneste/Tab

BioCryst Company profile

Om BioCryst

BioCryst Pharmaceuticals, Inc. (BioCryst) er en bioteknologisk virksomhed i den kommercielle fase, der udvikler småmolekylære lægemidler. Virksomheden fokuserer på orale behandlinger af sjældne sygdomme, hvor der er et udækket medicinsk behov, og hvor et enzym spiller en nøglerolle i den biologiske vej for sygdommen. ORLADEYO (berotralstat) er en oral, en gang daglig behandling, der er godkendt i USA, EU, Japan og Det Forenede Kongerige til forebyggelse af anfald af arveligt angioødem (HAE) hos voksne og pædiatriske patienter på 12 år og derover. BioCryst har flere igangværende udviklingsprogrammer, herunder BCX9930, en oral faktor D-hæmmer til behandling af komplementmedierede sygdomme; BCX9250, en aktivinreceptorlignende kinase-2 (ALK-2)-hæmmer til behandling af fibrodysplasia ossificans progressiva, og Galidesivir, et antiviralt lægemiddel til behandling af Marburgvirussygdom og gul feber. RAPIVAB (peramivir injektion) er en viral neuraminidasehæmmer til behandling af influenza.

Industry: Bio Therapeutic Drugs

4505 Emperor Blvd Ste 200
27703-8457

Resultatopgørelse

  • Annual
  • Quarterly

Folk ser også

Gold

1,971.01 Price
+0.700% 1D Chg, %
Long position, gebyr natten over -0.0180%
Short position, gebyr natten over 0.0097%
Gebyr natten over, tid 21:00 (UTC)
Spænd 0.30

BTC/USD

26,854.10 Price
-0.850% 1D Chg, %
Long position, gebyr natten over -0.0616%
Short position, gebyr natten over 0.0137%
Gebyr natten over, tid 21:00 (UTC)
Spænd 60.00

US100

12,540.70 Price
-1.000% 1D Chg, %
Long position, gebyr natten over -0.0241%
Short position, gebyr natten over 0.0018%
Gebyr natten over, tid 21:00 (UTC)
Spænd 1.8

XRP/USD

0.50 Price
+5.870% 1D Chg, %
Long position, gebyr natten over -0.0753%
Short position, gebyr natten over 0.0069%
Gebyr natten over, tid 21:00 (UTC)
Spænd 0.00471

Leder du stadig efter en mægler, du kan stole på?

Deltag sammen med 500.000+ handlende over hele verden, der valgte at handle hos Capital.com

1. Opret og bekræft din konto 2. Lav en inddbetaling 3. Find din handel